These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 29801583)

  • 21. Pharmacogenetics of oral antidiabetic treatment.
    Schroner Z; Javorsky M; Kozarova M; Tkac I
    Bratisl Lek Listy; 2011; 112(8):441-6. PubMed ID: 21863614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of factors associated with antidiabetic drug prescribing for type 2 diabetes mellitus.
    Mahmoud F; Mullen A; Sainsbury C; Rushworth GF; Yasin H; Abutheraa N; Mueller T; Kurdi A
    Eur J Clin Invest; 2023 Aug; 53(8):e13997. PubMed ID: 37002856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics of Anti-Diabetes Drugs.
    Distefano JK; Watanabe RM
    Pharmaceuticals (Basel); 2010 Aug; 3(8):2610-2646. PubMed ID: 20936101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycemic excursions are positively associated with HbA1c reduction from baseline after treatment with acarbose in patients with type 2 diabetes on metformin monotherapy.
    Wang JS; Lee IT; Lee WJ; Lin SD; Su SL; Tu ST; Tseng YH; Lin SY; Sheu WH
    J Diabetes; 2017 Mar; 9(3):248-255. PubMed ID: 27043224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes.
    Dujic T; Bego T; Malenica M; Velija-Asimi Z; Ahlqvist E; Groop L; Pearson ER; Causevic A; Semiz S
    Bosn J Basic Med Sci; 2019 Nov; 19(4):368-374. PubMed ID: 31070566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacogenetics of metformin.
    Florez JC
    Diabetologia; 2017 Sep; 60(9):1648-1655. PubMed ID: 28770331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT; Chang KC; Li CY; Wu JS
    Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective.
    Manolopoulos VG; Ragia G; Tavridou A
    Pharmacogenomics; 2011 Aug; 12(8):1161-91. PubMed ID: 21843065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus.
    Prudente S; Di Paola R; Pezzilli S; Garofolo M; Lamacchia O; Filardi T; Mannino GC; Mercuri L; Alberico F; Scarale MG; Sesti G; Morano S; Penno G; Cignarelli M; Copetti M; Trischitta V
    Pharmacogenomics J; 2018 May; 18(3):431-435. PubMed ID: 28696414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathways targeted by antidiabetes drugs are enriched for multiple genes associated with type 2 diabetes risk.
    Segrè AV; Wei N; ; ; Altshuler D; Florez JC
    Diabetes; 2015 Apr; 64(4):1470-83. PubMed ID: 25368101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Outcomes After Initiating Triple Antidiabetic Therapy with a GLP-1 RA in an Integrated Health Care System.
    Lee SM; Aboubechara N; Niu F; Ledesma VM; Patel YA; Millares M; Hui RL
    J Manag Care Spec Pharm; 2019 Mar; 25(3):350-356. PubMed ID: 30816819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country.
    Zaghloul N; Awaisu A; Mahfouz A; Alyafei S; Elewa H
    Int J Clin Pharm; 2022 Dec; 44(6):1342-1350. PubMed ID: 36169802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment intensification for patients with type 2 diabetes and poor glycaemic control.
    Fu AZ; Sheehan JJ
    Diabetes Obes Metab; 2016 Sep; 18(9):892-8. PubMed ID: 27160505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery.
    Zhou K; Pedersen HK; Dawed AY; Pearson ER
    Nat Rev Endocrinol; 2016 Jun; 12(6):337-46. PubMed ID: 27062931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis.
    Mearns ES; Sobieraj DM; White CM; Saulsberry WJ; Kohn CG; Doleh Y; Zaccaro E; Coleman CI
    PLoS One; 2015; 10(4):e0125879. PubMed ID: 25919293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update on the pharmacogenomics of metformin: progress, problems and potential.
    Todd JN; Florez JC
    Pharmacogenomics; 2014 Mar; 15(4):529-39. PubMed ID: 24624919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetic studies update in type 2 diabetes mellitus.
    Singh S; Usman K; Banerjee M
    World J Diabetes; 2016 Aug; 7(15):302-15. PubMed ID: 27555891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.
    Dawed AY; Yee SW; Zhou K; van Leeuwen N; Zhang Y; Siddiqui MK; Etheridge A; Innocenti F; Xu F; Li JH; Beulens JW; van der Heijden AA; Slieker RC; Chang YC; Mercader JM; Kaur V; Witte JS; Lee MTM; Kamatani Y; Momozawa Y; Kubo M; Palmer CNA; Florez JC; Hedderson MM; 't Hart LM; Giacomini KM; Pearson ER; ;
    Diabetes Care; 2021 Dec; 44(12):2673-2682. PubMed ID: 34607834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of antidiabetic drugs with diabetic retinopathy in people with type 2 diabetes: an umbrella review and meta-analysis.
    Tan L; Wang Z; Okoth K; Toulis KA; Denniston AK; Singh BM; Crowe FL; Sainsbury C; Wang J; Nirantharakumar K
    Front Endocrinol (Lausanne); 2023; 14():1303238. PubMed ID: 38239984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.